PHARMACEUTICAL PREPARATIONS HORMONE REPLACEMENT
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| FEMOSTON | SOLVAY DUPHAR B.V. | C.J. VAN HOUTENLAAN 36 WEESP Netherlands | pharmaceutical preparations for hormone replacement therapy in women; |
| FEMOSTON | SOLVAY PHARMACEUTICALS B.V. | C.J. van Houtenlaan 36 NL-1381 CP Weesp Netherlands | pharmaceutical preparations for hormone replacement therapy in women; |
| FEMOSTON | ABBOTT PRODUCTS OPERATIONS AG | Hegenheimermattweg 127 Allschwil 4123 Switzerland | pharmaceutical preparations for hormone replacement therapy in women; |
| FEMRING | MILLICENT HOLDINGS, LTD. | 22 VICTORIA STREET CANON'S COURT HAMILTON HM12 Bermuda | PHARMACEUTICAL PREPARATIONS FOR HORMONE REPLACEMENT THERAPY;MEDICAL APPARATUS, NAMELY, INTRAVAGINAL RING FOR DELIVERY OF HORMONE RELEASE THERAPY PHARMACEUTICALS VIA THE VAGINA BY A CONTINUOUS RELEASE SYSTEM; |
| FEMRING | WARNER CHILCOTT (IRELAND) LIMITED | BELGARD ROAD TALLAGHT DUBLIN 24 Ireland | PHARMACEUTICAL PREPARATIONS FOR HORMONE REPLACEMENT THERAPY;MEDICAL APPARATUS, NAMELY, INTRAVAGINAL RING FOR DELIVERY OF HORMONE RELEASE THERAPY PHARMACEUTICALS VIA THE VAGINA BY A CONTINUOUS RELEASE SYSTEM; |
|
|
|||
| FEMRING | CTS ANALYTICAL LIMITED | UNIT 22 SEAGOE INDUSTRIAL ESTATE CRAIGAVON, CO ARMAGH, NORTHERN BT63 5UA Ireland | PHARMACEUTICAL PREPARATIONS FOR HORMONE REPLACEMENT THERAPY;MEDICAL APPARATUS, NAMELY, INTRAVAGINAL RING FOR DELIVERY OF HORMONE RELEASE THERAPY PHARMACEUTICALS VIA THE VAGINA BY A CONTINUOUS RELEASE SYSTEM; |
| OVESTIN | ASPEN GLOBAL INCORPORATED | GBS Plaza Cnr La Salette & Royal Roads Grand Bay BRNCO8078 Mauritius | Pharmaceutical preparations for hormone replacement therapy; |
| OVESTIN | Apen Global Incorporated | GBS Plaza Cnr La Salette & Royal Roads Grand Bay Mauritius | Pharmaceutical preparations for hormone replacement therapy; |
| OVESTIN | ASPEN GLOBAL INCORPORATED | GBS Plaza Cnr La Salette & Royal Roads Grand Bay BRNCO8078 Mauritius | Pharmaceutical preparations for hormone replacement therapy; |
| PURESTRA | Endeavor Pharmaceuticals | 127 Racine Drive Suite 202 Wilmington NC 28403 | PHARMACEUTICAL PREPARATIONS FOR HORMONE REPLACEMENT THERAPY; |
| XENCOR | XENCOR, INC. | 111 West Lemon Avenue Monrovia CA 91016 | PHARMACEUTICAL PREPARATIONS FOR HORMONE REPLACEMENT THERAPIES, CANCER GENE THERAPY, DIABETES THERAPY, T CELL THERAPY, BLOOD GROWTH FACTORS, NEURAL GROWTH FACTOR THERAPY, ANTI-COAGULANT THERAPY, BIOLOGICAL RESPONSE MODIFIER THERAPY, ANTI-CANCER ANTIBODY THERAPY, ANTI-VIRAL THERAPY, ANTI-MICROBIAL THERAPY, DRUG SCREENING REAGENTS, NAMELY, CYTOKINE RECEPTOR ASSAY REAGENTS, HIGH THROUGHPUT ASSAYS; BIOTECHNOLOGICAL PREPARATIONS FOR MEDICAL OR VETERINARY PURPOSES, BEING PULP AND PAPER PROCESSING ENZYMES, NAMELY, XYLANESE FOR BLEACH BOOSTING, PITCH REDUCTION LIPASES, CELLULASES FOR BLEACH BOOSTING; DETERGENT ENZYMES, NAMELY, DETERGENT PROTEASES, DETERGENT CELLULASES, DETERGENT LIPASES; WASTE REMEDIATION ENZYMES, NAMELY, DEHALOGENASE ENZYMES; BIOMASS PROCESSING ENZYMES, NAMELY, CELLULASES, AMYLASES, GLUCOAMYLASES; |
Where the owner name is not linked, that owner no longer owns the brand |
|||
Technical Examples
- The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.